Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20985)

• Formulation Name: Terbinafine 250 mg tablet
• Company: American Health Packaging; AvKARE; Bryant Ranch Prepack; Camber Pharmaceuticals; Carilion Materials Management; Cipla; Exelan Pharmaceuticals; Harris Pharmaceutical; Novartis Pharmaceuticals Corporation; PD-Rx Pharmaceuticals; Preferred Pharamaceuticals; Proficient Rx; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terbinafine	(DMI6HUW)	Fungal infection	1F29-1F2F	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent